AAAAAA

   
Results: 1-8 |
Results: 8
Protection and in vivo selection of hematopoietic stem cells using temozolomide, O-6-benzylguanine, and an alkyltransferase-expressing retroviral vector
Authors: Sawai, N Zhou, S Vanin, EF Houghton, P Brent, TP Sorrentino, BP
Citation: N. Sawai et al., Protection and in vivo selection of hematopoietic stem cells using temozolomide, O-6-benzylguanine, and an alkyltransferase-expressing retroviral vector, MOL THER, 3(1), 2001, pp. 78-87
Heterogeneous methylation of the O-6-methylguanine-DNA methyltransferase promoter in immortalized IMR90 cell lines
Authors: Danam, RP Howell, SR Remack, JS Brent, TP
Citation: Rp. Danam et al., Heterogeneous methylation of the O-6-methylguanine-DNA methyltransferase promoter in immortalized IMR90 cell lines, INT J ONCOL, 18(6), 2001, pp. 1187-1193
Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models
Authors: Middlemas, DS Stewart, CF Kirstein, MN Poquette, C Friedman, HS Houghton, PJ Brent, TP
Citation: Ds. Middlemas et al., Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models, CLIN CANC R, 6(3), 2000, pp. 998-1007
Antitumor activity of temozolomide combined with irinotecan is partly independent of O-6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models
Authors: Houghton, PJ Stewart, CF Cheshire, PJ Richmond, LB Kirstein, MN Poquette, CA Tan, M Friedman, HS Brent, TP
Citation: Pj. Houghton et al., Antitumor activity of temozolomide combined with irinotecan is partly independent of O-6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models, CLIN CANC R, 6(10), 2000, pp. 4110-4118
Extraneuronal monoamine transporter expression and DNA repair vis-a-vis 2-chloroethyl-3-sarcosinamide-1-nitrosourea cytotoxicity in human tumor cell lines
Authors: Chen, ZP Remack, J Brent, TP Mohr, G Panasci, LC
Citation: Zp. Chen et al., Extraneuronal monoamine transporter expression and DNA repair vis-a-vis 2-chloroethyl-3-sarcosinamide-1-nitrosourea cytotoxicity in human tumor cell lines, CLIN CANC R, 5(12), 1999, pp. 4186-4190
Methylation of selected CpGs in the human O-6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing
Authors: Danam, RP Qian, XC Howell, SR Brent, TP
Citation: Rp. Danam et al., Methylation of selected CpGs in the human O-6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing, MOL CARCINO, 24(2), 1999, pp. 85-89
A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers
Authors: Herfarth, KKF Brent, TP Danam, RP Remack, JS Kodner, IJ Wells, SA Goodfellow, PJ
Citation: Kkf. Herfarth et al., A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers, MOL CARCINO, 24(2), 1999, pp. 90-98
Modulation of cyclophosphamide activity by O-6-alkylguanine-DNA alkyltransferase
Authors: Friedman, HS Pegg, AE Johnson, SP Loktionova, NA Dolan, ME Modrich, P Moschel, RC Struck, R Brent, TP Ludeman, S Bullock, N Kilborn, C Keir, S Dong, Q Bigner, DD Colvin, OM
Citation: Hs. Friedman et al., Modulation of cyclophosphamide activity by O-6-alkylguanine-DNA alkyltransferase, CANC CHEMOT, 43(1), 1999, pp. 80-85
Risultati: 1-8 |